New hope for advanced breast cancer: first human trial of MEN2312 begins
NCT ID NCT06638307
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This early-stage trial tests a new drug called MEN2312, alone or with another drug (elacestrant), in 240 adults with advanced breast cancer that has specific genetic changes. The main goals are to find a safe dose and check for side effects. It is the first time MEN2312 is being tested in humans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MEN2312 (a KAT6 inhibitor) and elacestrant
- What this could lead to
- If successful, this could point toward a new treatment option for advanced breast cancer with specific genetic changes.
- What could go wrong
- This is an early Phase 1 trial, so safety and dosing are still being tested. It may not lead to an effective treatment, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advent Health Orlando
RECRUITINGAltamonte Springs, Florida, 32701, United States
-
Astera Cancer Care
RECRUITINGEast Brunswick, New Jersey, 08816, United States
-
City of Hope
RECRUITINGDuarte, California, 31010, United States
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Florida Cancer Specialists & Research Institute (FCS) - Sarasota
RECRUITINGSarasota, Florida, 34232, United States
-
Froedtert Hospital & the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Highlands Oncology Group
RECRUITINGSpringdale, Arkansas, 72703, United States
-
Hospital Clinico San Carlos
RECRUITINGMadrid, 484816, Spain
-
Hospital Clinico Universitario De Valencia Oncologia Medica
RECRUITINGValencia, 46010, Spain
-
Hospital Universitario 12 Octubre Servico de Oncologia Medica
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Vall d'Hebron - Vall d'Hebron Institute of Oncology (VHIO) Medical Oncology Department
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario y Politecnico La Fe Oncologia Medica
RECRUITINGValencia, 46026, Spain
-
IOB - Madrid Fundacion Hermanas Hospitalarias (Hospital Beata Maria Ana)
RECRUITINGMadrid, 28007, Spain
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Massachusetts General Hospital Cancer Center
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Perlmutter Cancer Center - Sunset Park
RECRUITINGBrooklyn, New York, 11220, United States
-
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
RECRUITINGMineola, New York, 11501, United States
-
Providence Cancer Institute Franz Clinic
RECRUITINGPortland, Oregon, 97213, United States
-
SCRI Oncology Partners Group
RECRUITINGNashville, Tennessee, 37203, United States
-
START Madrid - Centro Integral Oncologico Clara Campal (CIOCC), Hospital HM Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
START Madrid - Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
START Midwest - Oncology
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START Mountain
RECRUITINGWest Valley City, Utah, 84119, United States
-
START San Antonio, LLC
RECRUITINGSan Antonio, Texas, 78229, United States
-
Sarah Cannon Research Institute at Florida Cancer Specialists
RECRUITINGOrlando, Florida, 32827, United States
-
Sidney Kimmel Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21287, United States
-
Stanford Cancer Center
RECRUITINGPalo Alto, California, 94304, United States
-
The University of Kansas Cancer Center
RECRUITINGFairway, Kansas, 66205, United States
-
The University of Texas M.D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
The West Clinic, PC dba West Cancer Center
RECRUITINGGermantown, Tennessee, 38138, United States
-
UC San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093-0698, United States
-
UCLA Hematology Oncology - Parkside
RECRUITINGSanta Monica, California, 90404, United States
-
UCSF Helen Diller Family Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94158, United States
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
-
University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center)
RECRUITINGChicago, Illinois, 60612, United States
-
University of Iowa Health Care
RECRUITINGIowa City, Iowa, 52242, United States
-
University of Texas Health Science Center San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
-
University of Wisconsin Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53792, United States
-
Winship Cancer Institute, Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
Yale Comprehensive Cancer Center
RECRUITINGNew Haven, Connecticut, 06511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Can a pill combo outpace chemotherapy for aggressive breast cancer?
- Blood tests could reveal hidden resistance in breast cancer
- Triple threat: three new targeted drugs join forces with immunotherapy to attack Hard-to-Treat breast cancer
- New drug sequence aims to outsmart advanced breast cancer
- Could a pill replace an IV for advanced breast cancer treatment?